Format

Send to

Choose Destination
Br J Haematol. 2019 Jun;185(5):998-1001. doi: 10.1111/bjh.15693. Epub 2018 Nov 22.

Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis.

Author information

1
Patient Insights, Optum, Johnston, RI, USA.
2
Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA.
3
Biopharma Strategic Consulting, LLC, San Francisco, CA, USA.
4
Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA.

KEYWORDS:

AL amyloidosis; NT-proBNP; SF-36; cardiac biomarker; health-related quality of life

PMID:
30467849
DOI:
10.1111/bjh.15693

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center